{"podcast":{"title":"Metabolic Mind","slug":"metabolic-mind-6253550","podcast_index_feed_id":6253550,"rss_url":"https://feeds.captivate.fm/metabolic-mind/","website_url":"https://metabolicmind.org/","image_url":"https://artwork.captivate.fm/d5c870fb-4d35-464f-8bde-33ce9e2b58c4/MM-Podcast-cover-final.png","author":"Bret Scher","episode_count":224,"summary":"Metabolic Mind is working to transform the study and treatment of mental disorders by exploring the connection between metabolism and brain health. Metabolic interventions like ketogenic therapy are being used to treat serious mental illnesses like Bipolar Disorder, Schizophrenia, and Major Depressive Disorder. We explore topics that can help you understand how Metabolic Psychiatry might help you or a loved one treat mental disorders Watch our videos at https://www.youtube.com/@metabolicmind Our channel is for information only. Consult your physician before changing your lifestyle or medications.","last_synced_at":"2026-07-24T00:18:08.497488+00:00","page_url":"https://stenobird.com/podcast/metabolic-mind-6253550"},"episode":{"title":"GLP-1s, Weight Loss, and the Stigma We Don’t Talk About","slug":"glp-1s-weight-loss-and-the-stigma-we-don-t-talk-about","published_at":"2026-05-25T13:17:00+00:00","page_url":"https://stenobird.com/podcast/metabolic-mind-6253550/glp-1s-weight-loss-and-the-stigma-we-don-t-talk-about","show_page_url":"https://stenobird.com/podcast/metabolic-mind-6253550","url":"https://metabolicmind.org/","audio_url":"https://episodes.captivate.fm/episode/1638a6a3-44eb-4e86-b1c1-68e2bf8d0d28.mp3","summary":"A recent report highlighted a surprising trend: individuals using GLP-1 medications such as Ozempic and Wegovy may be facing even more social stigma than those who remain overweight. And while neither deserves any stigma at all, it raises an important question about how we judge health choices in modern medicine. In this conversation, Dr. Bret Scher reflects on whether his own critiques of GLP-1 medications stem from bias against the individuals using them. His conclusion is clear: the issue is not the patient, but the system surrounding care. While GLP-1 receptor agonists can be powerful tools for weight loss and metabolic improvement, Dr. Scher emphasizes a deeper concern: the growing tendency toward a “drug-first” model that may overlook foundational lifestyle and metabolic interventions such as nutrition quality, protein intake, resistance training, and long-term behavior change. Key themes discussed: The stigma patients face regardless of whether they lose weight or not The difference between criticizing a treatment and blaming the patient Concerns about overprescribing without adequate lifestyle support What happens when medications are stopped (and weight is regained) The importance of metabolic health beyond the scale This conversation also highlights the complexity of long-term care. While some individuals may benefit significantly from GLP-1 medications, sustainable metabolic health ideally integrates medical tools with lifestyle-based strategies that support long-term resilience. 🔎 Have questions about how to apply metabolic therapies effectively? Submit them at metabolicmind.org/questions to be featured in a future Metabolic Mailbag episode. #MetabolicMind #KetogenicTherapy #FoodAsMedicine Expert Featured: Dr. Bret Scher Baszucki Group Medical Director http…","meta_description":"A recent report highlighted a surprising trend: individuals using GLP-1 medications such as Ozempic and Wegovy may be facing even more social stigma than…","key_points":[],"chapters":[],"topics":[],"duration_seconds":279,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/metabolic-mind-6253550/episodes/glp-1s-weight-loss-and-the-stigma-we-don-t-talk-about/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/metabolic-mind-6253550/glp-1s-weight-loss-and-the-stigma-we-don-t-talk-about.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}